예르시니아 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Yersinia Diagnostics Market size is expected to reach USD 6.43 Billion in 2034 from USD 4.22 Billion (2025) growing at a CAGR of 4.79% during 2026-2034.

The Global Yersinia Diagnostics Market is gaining momentum due to the rising prevalence of foodborne infections caused by Yersinia species, particularly Yersinia enterocolitica. Growing awareness about bacterial gastrointestinal infections and improved surveillance systems are contributing to higher diagnostic testing rates. Increasing cases linked to contaminated food and water supplies are further driving demand for accurate and rapid diagnostic solutions.

Technological advancements in molecular diagnostics, including PCR-based testing and rapid immunoassays, are key growth drivers. Hospitals and diagnostic laboratories are adopting automated systems for faster and more precise detection. Government initiatives aimed at strengthening food safety regulations and disease monitoring programs are also supporting market expansion across both developed and developing countries.

In the coming years, the market is expected to benefit from advancements in point-of-care testing and multiplex diagnostic platforms. Integration of digital health technologies and laboratory automation will improve efficiency and turnaround times. Rising investments in public health infrastructure and infectious disease research will further accelerate growth, positioning the Yersinia diagnostics market for steady expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Types

• Stool Culture
• ELISA
• Radioimmunoassay
• Tube Agglutination
• CT Scan
• Ultrasonography
• Colonoscopy

By Techniques

• PCR
• DNA Probes
• Monoclonal Antibodies
• Immunoassay
• IT
• Others

COMPANIES PROFILED

• GenProbe, BioRad, Affymetrix Inc, Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Becton Dickinson, Hologic Inc, PerkinElmer
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TEST TYPES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Types
• 4.2. Stool Culture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Radioimmunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Tube Agglutination Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Ultrasonography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Colonoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY TECHNIQUES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Techniques
• 5.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. DNA Probes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. IT Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL YERSINIA DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Types
  • 6.2.2 By Techniques
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Types
  • 6.3.2 By Techniques
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Types
  • 6.4.2 By Techniques
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Types
  • 6.5.2 By Techniques
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Types
  • 6.6.2 By Techniques
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL YERSINIA DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Gen-Probe
  • 8.2.2 Bio-Rad
  • 8.2.3 Affymetrix Inc
  • 8.2.4 Abbott Laboratories
  • 8.2.5 Roche Diagnostics
  • 8.2.6 Thermo Fisher Scientific
  • 8.2.7 Qiagen
  • 8.2.8 Becton Dickinson
  • 8.2.9 Hologic Inc
  • 8.2.10 PerkinElmer